119 related articles for article (PubMed ID: 11704798)
41. [Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia].
Beránek M; Voglová J; Sýkorová A; Belada D; Bláha M
Cas Lek Cesk; 2006; 145(1):25-9; discussion 29-30. PubMed ID: 16468238
[TBL] [Abstract][Full Text] [Related]
42. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
[TBL] [Abstract][Full Text] [Related]
43. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia.
Jándula BM; Nomdedeu J; Marín P; Vivancos P
Bone Marrow Transplant; 2001 Jan; 27(2):225-7. PubMed ID: 11281397
[TBL] [Abstract][Full Text] [Related]
44. Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results.
Gaziev D; Galimberti M; Polchi P; Angelucci E; Giardini C; Baronciani D; Andreani M; Persini B; Erer B; Sodani P; Manna M; Nicolini G; Visani G; Lucarelli G;
Bone Marrow Transplant; 2002 Jan; 29(1):1-8. PubMed ID: 11840137
[TBL] [Abstract][Full Text] [Related]
45. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
Chiorean EG; DeFor TE; Weisdorf DJ; Blazar BR; McGlave PB; Burns LJ; Brown C; Miller JS
Biol Blood Marrow Transplant; 2004 Mar; 10(3):171-7. PubMed ID: 14993882
[TBL] [Abstract][Full Text] [Related]
46. Biological importance of residual leukaemic cells after BMT for CML: does the polymerase chain reaction help?
Hughes TP; Goldman JM
Bone Marrow Transplant; 1990 Jan; 5(1):3-6. PubMed ID: 2404529
[TBL] [Abstract][Full Text] [Related]
47. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
48. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
[TBL] [Abstract][Full Text] [Related]
49. Preemptive treatment of minimal residual disease post transplant in CML using real-time quantitative RT-PCR: a prospective, randomized trial.
Kim YJ; Kim DW; Lee S; Chung NG; Hwang JY; Kim YL; Min CK; Kim CC
Bone Marrow Transplant; 2004 Mar; 33(5):535-42. PubMed ID: 14716340
[TBL] [Abstract][Full Text] [Related]
50. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation.
Au WY; Lam CC; Lie AK; Pang A; Kwong YL
Am J Clin Pathol; 2003 Oct; 120(4):626-30. PubMed ID: 14560574
[TBL] [Abstract][Full Text] [Related]
51. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ
Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of relapsed CML after cord blood transplantation with donor leukocyte infusion IL-2 and IFNalpha.
Laws HJ; Nürnberger W; Körholz D; Kögler G; Fischer J; Niehues T; Wernet P; Göbel U
Bone Marrow Transplant; 2000 Jan; 25(2):219-22. PubMed ID: 10673686
[TBL] [Abstract][Full Text] [Related]
53. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia.
Molldrem JJ; Lee PP; Wang C; Felio K; Kantarjian HM; Champlin RE; Davis MM
Nat Med; 2000 Sep; 6(9):1018-23. PubMed ID: 10973322
[TBL] [Abstract][Full Text] [Related]
54. Chronic myeloid leukemia.
Sawyers CL
N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
[No Abstract] [Full Text] [Related]
55. Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML--a case report.
Lönnqvist B; Brune M; Ljungman P
Bone Marrow Transplant; 1996 Jul; 18(1):241-2. PubMed ID: 8832027
[TBL] [Abstract][Full Text] [Related]
56. [Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
Hasegawa A; Ninomiya H; Yanagisawa K; Takada K; Hasegawa H; Hato T; Yasukawa M; Fujita S
Rinsho Ketsueki; 1996 Sep; 37(9):853-7. PubMed ID: 8914475
[TBL] [Abstract][Full Text] [Related]
57. [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
Steegmann JL; Granados E; Rodríguez-Salvanés F; Casado LF; Giraldo P; Lavilla E; Gómez-Casares MT; Fernández-Contreras E; Odriozola J
Sangre (Barc); 1998 Apr; 43(2):137-46. PubMed ID: 9656775
[No Abstract] [Full Text] [Related]
58. [An allogeneic bone marrow transplantation for chronic myelocytic leukemia with a large extramedullary tumor in the pelvic cavity].
Yoshida M; Takahashi T; Kimura H; Mita H; Horiuchi S; Tanimura A; Adachi M; Hinoda Y; Imai K
Rinsho Ketsueki; 1996 Sep; 37(9):838-42. PubMed ID: 8914472
[TBL] [Abstract][Full Text] [Related]
59. Two siblings with chronic myelogenous leukemia.
Kapsali E; Tsiara S; Christou L; Panteli A; Bourantas KL
J Exp Clin Cancer Res; 2000 Dec; 19(4):541-3. PubMed ID: 11277336
[TBL] [Abstract][Full Text] [Related]
60. [Results of treatment of children with chronic myelogenous leukaemia (CML) obtained by the Polish Paediatric Leukaemia/Lymphoma Study Group].
Chybicka A; Kałwak K; Bogusławska-Jaworska J; Turkiewicz D; Armata J; Balcerska A; Bubała H; Boruczkowski D; Cwiklińska M; Hicke A; Kaczmarek-Kanold M; Kolecki P; Kowalczyk J; Krauze A; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sikorska-Fic B; Staszak-Kowalska R; Tomaszewska R; Wiśniewska-Slusarz H; Wachowiak J; Wysocki M;
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):49-55. PubMed ID: 12021462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
